Brief reportsUsefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology
References (15)
- et al.
Primary pulmonary hypertension between inflammation and cancer
Chest
(1998) - et al.
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial
Ann Intern Med
(1990) - et al.
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
N Engl J Med
(1996) - et al.
Vasodilator therapy for primary pulmonary hypertension in children
Circulation
(1999) - et al.
Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects
Circulation
(1999) - et al.
Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue
Hum Pathol
(1980) - et al.
Primary pulmonary hypertensiona vascular biology and translational research “work in progress”
Circulation
(2000)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2003 Excerpta Medica Inc. All rights reserved.